Stephens Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) Stock

Cognex (NASDAQ:CGNXGet Free Report) had its price target increased by analysts at Stephens from $65.00 to $75.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the scientific and technical instruments company’s stock. Stephens’ price target would indicate a potential upside of 14.22% from the company’s previous close.

Several other research firms also recently weighed in on CGNX. Cantor Fitzgerald restated an “overweight” rating and issued a $63.00 target price on shares of Cognex in a research report on Friday, February 13th. Needham & Company LLC raised their target price on Cognex from $47.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Raymond James Financial restated a “strong-buy” rating on shares of Cognex in a research report on Thursday, February 12th. Barclays raised their target price on Cognex from $61.00 to $64.00 and gave the company an “overweight” rating in a research report on Monday, March 16th. Finally, Robert W. Baird set a $55.00 target price on Cognex in a research report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, Cognex has a consensus rating of “Moderate Buy” and a consensus target price of $67.21.

Check Out Our Latest Stock Report on Cognex

Cognex Trading Down 0.4%

Shares of CGNX stock opened at $65.66 on Thursday. The company has a market capitalization of $10.97 billion, a P/E ratio of 78.17 and a beta of 1.48. The business’s 50 day moving average is $52.67 and its two-hundred day moving average is $45.20. Cognex has a 12-month low of $29.00 and a 12-month high of $71.90.

Cognex (NASDAQ:CGNXGet Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.09. The company had revenue of $268.44 million for the quarter, compared to the consensus estimate of $245.98 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.Cognex’s revenue for the quarter was up 24.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, research analysts predict that Cognex will post 0.97 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, VP Laura Ann Macdonald sold 14,881 shares of Cognex stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total transaction of $850,597.96. Following the transaction, the vice president owned 2,212 shares in the company, valued at approximately $126,437.92. This trade represents a 87.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert Willett sold 177,052 shares of Cognex stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total value of $10,338,066.28. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 196,083 shares of company stock worth $11,419,321. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Cognex

A number of institutional investors have recently added to or reduced their stakes in CGNX. Oppenheimer Asset Management Inc. boosted its holdings in Cognex by 13.3% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 318,984 shares of the scientific and technical instruments company’s stock valued at $14,450,000 after acquiring an additional 37,405 shares during the period. Nordea Investment Management AB boosted its holdings in Cognex by 0.9% during the 4th quarter. Nordea Investment Management AB now owns 8,101,583 shares of the scientific and technical instruments company’s stock valued at $292,224,000 after acquiring an additional 76,212 shares during the period. IMC Chicago LLC purchased a new position in Cognex during the 3rd quarter valued at about $5,761,000. Bank of New York Mellon Corp boosted its holdings in Cognex by 43.9% during the 3rd quarter. Bank of New York Mellon Corp now owns 3,024,355 shares of the scientific and technical instruments company’s stock valued at $137,003,000 after acquiring an additional 922,149 shares during the period. Finally, DAVENPORT & Co LLC boosted its holdings in Cognex by 19.1% during the 4th quarter. DAVENPORT & Co LLC now owns 477,658 shares of the scientific and technical instruments company’s stock valued at $17,186,000 after acquiring an additional 76,540 shares during the period. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Cognex News Summary

Here are the key news stories impacting Cognex this week:

  • Positive Sentiment: Cognex reported Q1 earnings of $0.34 per share, beating estimates, while revenue came in at $268.4 million, also above expectations and up 24.3% year over year.
  • Positive Sentiment: Management issued bullish Q2 guidance for EPS of $0.40 to $0.44 and revenue of $280 million to $300 million, signaling continued demand strength in automation and logistics.
  • Positive Sentiment: Analysts turned more constructive after the report: Needham raised its price target to $75 and kept a Buy rating, while Stephens also lifted its target to $75 with an Overweight rating.
  • Positive Sentiment: The company’s new AI-powered In-Sight systems and broad-based demand strength are reinforcing the view that Cognex can sustain growth and margin expansion.
  • Neutral Sentiment: JPMorgan raised its price target to $65 but maintained a Neutral rating, suggesting some analysts still see limited upside after the recent run-up. Benzinga
  • Neutral Sentiment: The company also declared a quarterly dividend of $0.085 per share, a modest positive for income-focused investors.

About Cognex

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Read More

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.